These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. NCOA4-mediated ferritinophagy promotes ferroptosis induced by erastin, but not by RSL3 in HeLa cells. Gryzik M; Asperti M; Denardo A; Arosio P; Poli M Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118913. PubMed ID: 33245979 [TBL] [Abstract][Full Text] [Related]
6. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines. Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532 [TBL] [Abstract][Full Text] [Related]
7. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3. Shintoku R; Takigawa Y; Yamada K; Kubota C; Yoshimoto Y; Takeuchi T; Koshiishi I; Torii S Cancer Sci; 2017 Nov; 108(11):2187-2194. PubMed ID: 28837253 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression. Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3ε. Vučković AM; Bosello Travain V; Bordin L; Cozza G; Miotto G; Rossetto M; Toppo S; Venerando R; Zaccarin M; Maiorino M; Ursini F; Roveri A FEBS Lett; 2020 Feb; 594(4):611-624. PubMed ID: 31581313 [TBL] [Abstract][Full Text] [Related]
10. Differential cell death decisions in the testis: evidence for an exclusive window of ferroptosis in round spermatids. Bromfield EG; Walters JLH; Cafe SL; Bernstein IR; Stanger SJ; Anderson AL; Aitken RJ; McLaughlin EA; Dun MD; Gadella BM; Nixon B Mol Hum Reprod; 2019 May; 25(5):241-256. PubMed ID: 30865280 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of GPX4 drives ferroptosis resistance in scleroderma skin fibroblasts. Zhang F; Xiao Y; Huang Z; Wang Y; Wan W; Zou H; Wang B; Qiu X; Yang X Free Radic Biol Med; 2024 Aug; 221():23-30. PubMed ID: 38740100 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. Baba Y; Higa JK; Shimada BK; Horiuchi KM; Suhara T; Kobayashi M; Woo JD; Aoyagi H; Marh KS; Kitaoka H; Matsui T Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H659-H668. PubMed ID: 29127238 [TBL] [Abstract][Full Text] [Related]
13. Protection of HT22 neuronal cells against chemically-induced ferroptosis by catechol estrogens: protein disulfide isomerase as a mechanistic target. Huang X; Hou MJ; Zhu BT Sci Rep; 2024 Oct; 14(1):23988. PubMed ID: 39402104 [TBL] [Abstract][Full Text] [Related]
14. Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways. Son JY; Yoon S; Tae IH; Park YJ; De U; Jeon Y; Park YJ; Rhyu IJ; Lee BM; Chung KH; Lim JE; Lee SJ; Lee HW; Kwak JH; Kim HS; Choi HY Cancer Med; 2018 Oct; 7(10):5083-5095. PubMed ID: 30160042 [TBL] [Abstract][Full Text] [Related]
15. SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levels. Han D; Jiang L; Gu X; Huang S; Pang J; Wu Y; Yin J; Wang J J Cell Physiol; 2020 Nov; 235(11):8839-8851. PubMed ID: 32329068 [TBL] [Abstract][Full Text] [Related]
16. Ferroptosis inducer erastin downregulates androgen receptor and its splice variants in castration‑resistant prostate cancer. Yang Y; Liu T; Hu C; Xia H; Liu W; Chen J; Wu S; Jiang Y; Xu Y; Liu W; Zhao L Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649848 [TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-inducing compounds synergize with docetaxel to overcome chemoresistance in docetaxel-resistant non-small cell lung cancer cells. Huang W; Guo Y; Qian Y; Liu X; Li G; Wang J; Yang X; Wu M; Fan Y; Luo H; Chen Y; Zhang L; Yang N; Liu Z; Liu Y Eur J Med Chem; 2024 Oct; 276():116670. PubMed ID: 39018922 [TBL] [Abstract][Full Text] [Related]
18. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer. Shin D; Kim EH; Lee J; Roh JL Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884 [TBL] [Abstract][Full Text] [Related]
19. Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression. Chen WJ; Pan XW; Song X; Liu ZC; Xu D; Chen JX; Dong KQ; Di SC; Ye JQ; Gan SS; Wang LH; Zhou W; Cui XG Cancer Lett; 2024 Jul; 593():216963. PubMed ID: 38768682 [TBL] [Abstract][Full Text] [Related]
20. Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade Ferroptosis. Ni W; Li Y; Liang L; Yang S; Zhan M; Lu C; Lu L; Wen L J Biomed Nanotechnol; 2022 Feb; 18(2):327-342. PubMed ID: 35484753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]